DE3860245D1 - Antiarrhythmische mittel. - Google Patents

Antiarrhythmische mittel.

Info

Publication number
DE3860245D1
DE3860245D1 DE8888302599T DE3860245T DE3860245D1 DE 3860245 D1 DE3860245 D1 DE 3860245D1 DE 8888302599 T DE8888302599 T DE 8888302599T DE 3860245 T DE3860245 T DE 3860245T DE 3860245 D1 DE3860245 D1 DE 3860245D1
Authority
DE
Germany
Prior art keywords
formula
arrhythmic agents
chem
group
alkanesulphonamido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888302599T
Other languages
English (en)
Inventor
Peter Edward Dr Cross
John Edmund Dr Arrowsmith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Application granted granted Critical
Publication of DE3860245D1 publication Critical patent/DE3860245D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8888302599T 1987-03-25 1988-03-24 Antiarrhythmische mittel. Expired - Lifetime DE3860245D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707122A GB8707122D0 (en) 1987-03-25 1987-03-25 Antiarrhythmic agents

Publications (1)

Publication Number Publication Date
DE3860245D1 true DE3860245D1 (de) 1990-07-26

Family

ID=10614608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888302599T Expired - Lifetime DE3860245D1 (de) 1987-03-25 1988-03-24 Antiarrhythmische mittel.

Country Status (11)

Country Link
US (2) US4829071A (de)
EP (1) EP0286277B1 (de)
JP (1) JPS63255266A (de)
AT (1) ATE53996T1 (de)
DE (1) DE3860245D1 (de)
DK (1) DK170201B1 (de)
ES (1) ES2016408B3 (de)
GB (1) GB8707122D0 (de)
GR (1) GR3000581T3 (de)
IE (1) IE60004B1 (de)
PT (1) PT87050B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8707122D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
HU224354B1 (hu) * 1995-02-01 2005-08-29 Pharmacia & Upjohn Company 2-Aminoindán-származékok alkalmazása és az ezeket tartalmazó gyógyszerkészítmények
DE19547263C2 (de) * 1995-12-07 1999-04-29 Cardiotec Inc Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6083991A (en) 1997-06-04 2000-07-04 University Of Florida Research Foundation, Inc. Anti-arrhythmic composition and methods of treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2456911A (en) * 1945-05-04 1948-12-21 Wyeth Corp Disubstituted acetamidyl derivatives of amino quinolines
GB1024650A (en) * 1961-11-03 1966-03-30 Byk Gulden Lomberg Chem Fab Benzofuran derivatives and process for their production
US3513239A (en) * 1967-03-15 1970-05-19 Smithkline Corp Pharmaceutical compositions containing 2-aminoalkyl coumaran derivatives and methods of treating depression therewith
US3923813A (en) * 1969-12-19 1975-12-02 Christiaens Sa A Derivatives of 2-aminoindanes
US4192888A (en) * 1978-04-10 1980-03-11 Smithkline Corporation Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase
CA1175851A (en) * 1980-09-26 1984-10-09 Beecham Group Limited Secondary amines
US4435422A (en) * 1982-09-15 1984-03-06 Abbott Laboratories 5-Substituted 2,3-dihydrobenzofuran-2-carboxylic acids and their use in diuretic compositions
US4656190A (en) * 1983-11-14 1987-04-07 Merck & Co., Inc. Indene derivatives and their use as PAF-antagonists
DE3566886D1 (en) * 1984-05-04 1989-01-26 Upjohn Co N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
GB8412045D0 (en) * 1984-05-11 1984-06-20 Unilever Plc Detergent compositions
GB8707122D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents

Also Published As

Publication number Publication date
GB8707122D0 (en) 1987-04-29
GR3000581T3 (en) 1991-07-31
IE60004B1 (en) 1994-05-18
PT87050A (pt) 1988-04-01
DK160688D0 (da) 1988-03-24
US5130334A (en) 1992-07-14
JPS63255266A (ja) 1988-10-21
PT87050B (pt) 1992-07-31
DK160688A (da) 1989-01-10
DK170201B1 (da) 1995-06-12
IE880886L (en) 1988-09-25
ES2016408B3 (es) 1990-11-01
EP0286277A1 (de) 1988-10-12
EP0286277B1 (de) 1990-06-20
US4829071A (en) 1989-05-09
JPH0518828B2 (de) 1993-03-15
ATE53996T1 (de) 1990-07-15

Similar Documents

Publication Publication Date Title
FI906045A0 (fi) Kvaevehaltiga spirocykliska foereningar.
ATE80617T1 (de) Mittel zur ortsspezifischen alkylierung.
DE69021679D1 (de) Verwendung von Bis(3,4-Dialkylbenzyliden)sorbitolacetale und diese enthaltende Zusammensetzungen.
DE3861484D1 (de) Indanamin-derivate als antiarrhythmische mittel.
DE3860245D1 (de) Antiarrhythmische mittel.
ATE97410T1 (de) 6-amino-6-desoxyfumagillole, ihre herstellung und ihre verwendung.
DE3861155D1 (de) Antiarrhythmische mittel.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES516362A0 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
ATE134608T1 (de) 1-alkoxy-naphtalen-2-carboxamid-derivate mit hoher affinität für das 5-ht1a rezeptor von serotonin
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
DK17785D0 (da) Propanolderivater
FI882332A (fi) Antiarrytmiska medel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee